Neuren Pharmaceuticals Limited (ASX:NEU)
Australia
· Delayed Price · Currency is AUD 19.70
+0.31 (1.60%)
Sep 29, 2025, 4:13 PM AEST
Neuren Pharmaceuticals Market Cap
Neuren Pharmaceuticals has a market cap or net worth of 2.45 billion as of September 29, 2025. Its market cap has increased by 40.36% in one year.
Market Cap
2.45B
Enterprise Value
2.15B
Revenue
218.86M
Ranking
n/a
PE Ratio
16.89
Stock Price
19.70
Market Cap Chart
Since February 3, 2005, Neuren Pharmaceuticals's market cap has increased from 20.93M to 2.45B, an increase of 11,601.65%. That is a compound annual growth rate of 25.93%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 93.96B |
| Pro Medicus | 31.54B |
| Cochlear | 18.31B |
| Sonic Healthcare | 10.45B |
| Ramsay Health Care | 7.31B |
| Telix Pharmaceuticals | 5.03B |
| Ansell | 4.57B |
| Mesoblast | 3.07B |